DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 1966202
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1966202
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Dec 24, 2027 | Incyte Corp | JAKAFI | ruxolitinib phosphate |
Start Trial | Dec 24, 2027 | Incyte Corp | JAKAFI | ruxolitinib phosphate |
Start Trial | Dec 12, 2026 | Incyte Corp | JAKAFI | ruxolitinib phosphate |
Start Trial | Dec 12, 2026 | Incyte Corp | JAKAFI | ruxolitinib phosphate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |